Sameer Bansilal

机构：Alnylam Pharmaceuticals (United States)

发表论文 129 篇 · 总被引 8958 次 · h-index 33

代表论文

• Technology-Enabled Clinical Trials (2019 · Circulation · 被引 86)
• Child Health Promotion in Underserved Communities (2019 · Journal of the American College of Cardiology · 被引 58)
• Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone (2023 · JAMA Cardiology · 被引 36)
• Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54 (2022 · European Heart Journal · 被引 27)
• Grenada Heart Project–Community Health ActioN to EncouraGe healthy BEhaviors (GHP-CHANGE): A randomized control peer group–based lifestyle intervention (2019 · American Heart Journal · 被引 26)
• Different Lifestyle Interventions in Adults From Underserved Communities (2019 · Journal of the American College of Cardiology · 被引 18)